ZBH Stock Forecast & Price Target

Zimmer Biomet Holdings is a global leader in orthopedic implants and surgical equipment. The company has a strong market share in the reconstructive market, which accounts for two-thirds of its total revenue. With a focus on innovation and expanding its market reach through strategic acquisitions, the company is poised for long-term growth. Despite facing some headwinds in the knee market and disruptions in its salesforce transition, Zimmer Biomet remains committed to its transformation and its management continues to invest in growth opportunities, making it a solid investment opportunity.

Zimmer Biomet Holdings is facing margin pressures, rising cost pressures, and slower revenue and EPS growth compared to its peers. With its sales force transformation efforts not expected to materialize until 2027, the company will likely struggle to achieve its long-term goals and may see a further compression in its valuation. While the stock may present a short-term trade opportunity, we recommend a cautious approach and maintain a hold rating until there is more clarity on the company's ability to accelerate growth and overcome its challenges.